Boundary Capital — Full Portfolio
30 tracked investments · listed companies and verified rows first
Bodyswaps provides immersive learning experiences, likely VR or virtual simulations, for educational institutions including further education colleges and apprenticeship providers.
AI & Machine LearningEdTechSaaSLondon, GB
Christophe Mallet(Chief Executive Officer)inTom Szirtes(Chief Product & Technology Officer)inJulien Denoel(Chief Operations Officer)in
Co-investorsHaatchUfi VocTech Trust
Glyconics develops medical diagnostic devices using spectroscopy (light-with-matter technology) to support low-cost medical diagnosis and disease management for patients and healthcare practice.
Deep TechDigital HealthHealthtechMedical Devices
Andrew Round(Chief Executive Officer (ad interim))Dr. Päivi Maria Paldánius(Chief Medical Officer & Chief Operating Officer)Sebastien Cuvelier Mussalian(Chief Technology Officer)Dr. Phil Taday(Head of R&D)Paul Jesson(Chief Finance Officer)
Co-investorsAnglia Capital GroupDeepbridge Capital
This page is a podcast interview/article about Empirical Ventures, not a company website.
AI & Machine LearningDeep TechFintechLondon, GB
Johnathan Matlock(Co-founder and General Partner)
Advanced wound care therapy delivering continuous topical oxygen to accelerate healing.
Co-investorsAmadeus Capital Partners
Supplies machines and supplies that kill weeds without using herbicides.
Co-investorsCalculus Capital Ltd.Calculus
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
BC ABBC Dymag MAIN HIGH RESBC EchionBC glyconicsBitcoin Farming AdvisoryBusinessBusiness MatchingBusiness StrategyCelixirDesktop GeneticsFinancialImage ScanInductosenseInvestingInvestmentMarket ResearchMeetingMergerMerger AcquisitionPlanningResearchStockTorsionTorsion Information SecurityWarwick Analytics
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.













